Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Interesting stats for instys....

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 348
Posts 46,360
Boards Moderated 26
Alias Born 09/20/01
160x600 placeholder
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems GlobeNewswire Inc. - 1/14/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 9:24:22 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/18/2020 9:22:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 5:15:40 PM
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors GlobeNewswire Inc. - 12/17/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2020 6:05:19 AM
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submissi... GlobeNewswire Inc. - 12/2/2020 1:22:29 PM
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil GlobeNewswire Inc. - 11/13/2020 4:40:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 5:11:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:17:04 PM
Chembio Diagnostics Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/5/2020 4:05:00 PM
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire Inc. - 10/23/2020 8:00:10 AM
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System GlobeNewswire Inc. - 10/15/2020 5:55:10 PM
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System GlobeNewswire Inc. - 10/2/2020 7:26:09 AM
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System GlobeNewswire Inc. - 9/8/2020 6:01:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 7:43:29 AM
Chembio Diagnostics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 7:19:40 AM
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020 GlobeNewswire Inc. - 7/23/2020 4:10:10 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 10:00:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 9:43:40 AM
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues GlobeNewswire Inc. - 7/6/2020 4:23:03 PM
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen Sy... GlobeNewswire Inc. - 7/6/2020 4:11:10 PM
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System GlobeNewswire Inc. - 7/6/2020 4:10:10 PM
Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results GlobeNewswire Inc. - 7/1/2020 5:00:10 PM
XenaLives Member Level  Friday, 10/09/20 09:15:51 AM
Re: None
Post # of 456 
Interesting stats for instys....



Institutional movement:

Current - as of 6/30/20
Quote:

Institutional Owners 167
Shares Outstanding 20,161,500 shares
Institutional Shares 11,259,410 - 55.85% (ex 13D/G)


https://fintel.io/so/us/cemi

as of 3/31/20
Quote:

Institutional Owners 74
Shares Outstanding 20,161,500 shares
Institutional Shares 9,176,062 - 45.51% (ex 13D/G)


https://fintel.io/so/us/cemi?d=2020-03-31

as of 12/19/19
Quote:
Institutional Owners 73
Shares Outstanding 20,161,500 shares
Institutional Shares 10,211,291 - 50.65% (ex 13D/G)


https://fintel.io/so/us/cemi?d=2019-12-31

as of 06/30/19
Quote:

Institutional Owners 41
Shares Outstanding 20,161,500 shares
Institutional Shares 7,520,244 - 37.30% (ex 13D/G)(ex 13D/G)



as of 12/31/18
Quote:

Institutional Owners 42
Shares Outstanding 20,161,500 shares
Institutional Shares 7,506,683 - 37.23% (ex 13D/G)



as of 06/30/18
Quote:

Institutional Owners 33
Shares Outstanding 20,161,500 shares
Institutional Shares 6,371,216 - 31.60% (ex 13D/G)




Institutions that have recently sold out completely, note that the number of institutions holding has increased dramatically but share count has remained static since 2018 or before..


2020-05-15 13F Silvercrest Asset Management Group Llc 0 -100.00 0
2020-05-15 13F Orion Portfolio Solutions, LLC 0 -100.00 0
2020-05-15 13F Meeder Asset Management Inc 0 -100.00 0
2020-05-11 13F Gagnon Securities Llc 0 -100.00 0 -100.00
2020-05-11 13F Gagnon Advisors, LLC 0 -100.00 0
2020-05-06 13F/A Russell Investments Group, Ltd. 0 -100.00 0 -100.00
2020-04-29 13F Perkins Capital Management Inc 0 -100.00 0 -100.00
2020-04-22 13F Falcon Point Capital, Llc 0 -100.00 0
2020-04-15 13F Roubaix Capital, Llc 0 -100.00 0
2020-04-13 13F Valeo Financial Advisors, Llc 0 -100.00 0
2020-02-14 13F Acuta Capital Partners, Llc 0 -100.00 0
2020-02-14 13F Marshall Wace North America L.P. 0 -100.00 0
2020-02-14 13F Squarepoint Ops LLC 0 -100.00 0
2020-02-10 13F Barclays Plc 0 -100.00 0
2020-01-09 13F Quad Capital Management Advisors LLC 0 -100.00 0 -100.00
2020-01-09 13F Mesirow Financial Investment Management, Inc. 0 -100.00 0 -100.00
2019-11-14 13F Wexford Capital Lp 0 -100.00 0 -100.00
2019-11-14 13F/A Family Management Corp 0 -100.00 0 -100.00
2019-11-14 13F Deutsche Bank Ag\ 0 -100.00 0 -100.00
2019-11-13 13F Renaissance Technologies Llc 0 -100.00 0 -100.00
2019-10-16 13F Douglas Lane & Associates, LLC 0 -100.00 0 -100.00





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences